GLP-1 Price Index: October 2026 snapshot
Released · Last reviewed
On October 15, 2026, our compounded semaglutide index read 63.5 (July 2026 = 100): the median of the three basket programs we could price on their own pages fell to $119 a month, from $187.50 in July and September, when five of six inputs were provider-reported figures. The fall is mostly a change in evidence, not only in prices. Eden now charges $99 a month with no membership, OrderlyMeds' standing rate is $149, and Mochi, Henry Meds and MEDVi were left out because their pages print no complete all-in price. The sample is smaller, so treat the move as indicative.
Qualification: three basket programs (Mochi Health, Henry Meds, MEDVi) print no complete all-in price, so this snapshot is not like-for-like with July and September.
Market check, October 15, 2026: compounded semaglutide $49–$279 a month across 22 programs (median $99); compounded tirzepatide $86–$299 across 24 (median $144). Lowest all-in price each program prints on its own page.
What is in the index this month?
| Program | Effective monthly | Basis | Status | Source · read |
|---|---|---|---|---|
| Eden | $99 | month-to-month, no membership | Verified | eden.health · 2026-10-15 |
| NexLife Featured | $119 | 12-month plan; $139 month-to-month | Verified | nexlife.us · 2026-10-15 |
| OrderlyMeds | $149 | standard monthly rate ($74 new-customer starter excluded as introductory) | Verified | orderlymeds.com · 2026-10-15 |
| Mochi Health | — | $60–$99 by dose plus a membership whose amount is not printed | Excluded | joinmochi.com · 2026-10-15 |
| Henry Meds | — | "starts at $179/month", no product price | Excluded | henrymeds.com · 2026-10-15 |
| MEDVi | — | page prints placeholders; campaign page conflicts | Excluded | medvi.org · 2026-10-15 |
Median of $99, $119 and $149 = $119. Index = $119 ÷ $187.50 (July baseline median) × 100 = 63.5. Download: CSV · JSON · price history.
How has the index moved since July?
| Snapshot | Basket median | Index | Inputs priced | Verified first-party |
|---|---|---|---|---|
| July 15, 2026 | $187.50 | 100.0 | 6 | 1 |
| September 4, 2026 | $187.50 | 100.0 | 6 | 1 |
| October 15, 2026 | $119.00 | 63.5 | 3 | 3 |
Two things moved the number. Eden dropped its membership and now charges $99 a month for compounded semaglutide, against the $229 basket input we carried as a reported figure in September (other September pages listed Eden at $99 plus a $99 membership, $198 all-in). And the other reported inputs either rose on a first-party read (OrderlyMeds' standing rate is $149, not the $74 starter) or dropped out because the provider no longer prints a complete price. Earlier snapshots rested on five provider-reported figures; this one rests on three verified ones.
What does the wider market look like?
The basket is small by design: it is the set we have tracked since July. The wider October read covers every program whose own page we could price.
| Category | Programs | Low | Median | High |
|---|---|---|---|---|
| Compounded semaglutide, standard dose | 22 | $49 | $99 | $279 |
| Compounded tirzepatide, standard dose | 24 | $86 | $144 | $299 |
See every row on the semaglutide and tirzepatide comparison pages, or download the full dataset.
What is the lowest compounded price in the index today?
On October 15, 2026 the lowest figures in our index are conditional: WellMedr's fall sale and NextMeds' "as low as" price start compounded semaglutide at $49, and Collective's $69 tirzepatide plus its $199 yearly membership comes to about $86 a month. The lowest standing month-to-month prices with no membership are Mondae ($87 semaglutide, $126 tirzepatide) and Eden ($99 and $129).
What changed this month?
| Program | September 4 (status) | October 15 | Status now |
|---|---|---|---|
| Eden | semaglutide $99 + $99 membership; tirzepatide $199 + $99 (Provider Reported) | $99 and $129 a month, no membership fee | Verified |
| Found | $169 a month on a prepaid year, both molecules (Provider Reported) | semaglutide $169, tirzepatide $239 per 4-week cycle on 12 months; tirzepatide $359 month-to-month | Verified |
| Shed | semaglutide $175/$199/$249; tirzepatide $245/$279/$349 (Provider Reported) | semaglutide $159/$179/$199; tirzepatide $239/$269/$299 (12/6/1 months) | Verified |
| OrderlyMeds | semaglutide $74 (Provider Reported) | $149 a month standard; $74 is a 2-month new-customer starter | Verified |
| Mochi Health | $99/$199 + $79 membership (Provider Reported) | per-dose: semaglutide $60–$99, tirzepatide $90–$199, membership amount not printed | Verified, not ranked |
| Henry Meds | semaglutide $297 month-to-month (Provider Reported) | "starts at $179/month", no product price | Unpriced |
| MEDVi | semaglutide $299, tirzepatide $399 (Provider Reported) | page prints placeholders; a campaign page conflicts | Unpriced |
| Noom Med | semaglutide $199 (Provider Reported) | $279 a month after a $129 start, billed $837 per 12 weeks | Verified |
| NexLife microdose | tirzepatide $159/$149/$139/$129; semaglutide $129/$119/$114/$110 | tirzepatide tiles $189/$159/$150/$147; semaglutide figures conflict across NexLife's own pages | Verified / Conflicting Evidence |
| NexLife standard | semaglutide $139/$132/$125/$119; tirzepatide $169/$159/$149/$139 | unchanged | Verified |
How is the index calculated?
Effective monthly cost is the total of mandatory payments for a plan divided by the months it supplies, plus any membership you cannot decline. The basket median for July 2026 is set to 100; each snapshot's median is divided by it. Introductory-only prices and programs without a complete all-in price are excluded rather than given a placeholder. Full method: price-index methodology.
What are the limits of this number?
Three inputs is a thin sample, and the October value mixes real price changes with better evidence. Brand drugs, microdose plans and oral tablets are tracked separately and never blended in. Prices change often; each row carries its read date.
Frequently asked questions
What did the GLP-1 Price Index read on October 15, 2026?
On October 15, 2026, our compounded semaglutide index read 63.5 (July 2026 = 100): the median of the three basket programs we could price on their own pages fell to $119 a month, from $187.50 in July and September, when five of six inputs were provider-reported figures. The fall is mostly a change in evidence, not only in prices. Eden now charges $99 a month with no membership, OrderlyMeds' standing rate is $149, and Mochi, Henry Meds and MEDVi were left out because their pages print no complete all-in price. The sample is smaller, so treat the move as indicative.
What is the GLP-1 Price Index?
The GLP-1 Price Index is a dataset and website, published by US Peptides Partners LLC, that records what U.S. telehealth programs charge for compounded and brand GLP-1 medications, with the plan term, the evidence status and the date each price was read on the seller's own page. It reports the category median rather than the cheapest figure, keeps microdose, oral and brand prices in separate categories, and labels every price Verified, Provider Reported, Conflicting Evidence or Unpriced. The October 15, 2026 snapshot was read on the providers' own pages that day. The site is affiliate-supported, and NexLife is its featured provider.
How much does compounded semaglutide cost per month in October 2026?
As of October 15, 2026, the 22 compounded semaglutide programs we could price on their own pages charge between $49 and $279 a month at their lowest all-in rate, with a median of $99, counting any required membership and the cheapest plan term each program prints. The low end is made of sale and "as low as" prices: WellMedr's fall sale and NextMeds both start at $49. Standing month-to-month rates with no membership start at $87 (Mondae) and $99 (Eden). Compounded semaglutide is not FDA-approved.
How much does compounded tirzepatide cost per month in October 2026?
As of October 15, 2026, the 24 compounded tirzepatide programs we could price on their own pages charge between $86 and $299 a month at their lowest all-in rate, with a median of $144, counting any required membership and the cheapest plan term each program prints. The $86 figure is Collective's $69 monthly price plus its $199 annual membership spread over twelve months. Standing month-to-month rates with no membership start at $126 (Mondae) and $129 (Eden); as of November 6, 2026, NexLife is $129 month-to-month and $115 on a 12-month plan. Compounded tirzepatide is not FDA-approved.
Why does the same GLP-1 program show two different prices?
Most programs print a month-to-month price and a lower per-month price that requires a 3-, 6- or 12-month plan, so one program can show two figures that are both accurate; as of November 6, 2026, NexLife's tirzepatide is $129 month-to-month and $115 a month on 12 months. Other gaps come from a first-month promotion, a membership billed separately, or billing every four weeks, which means 13 charges a year. We compare programs on their all-in monthly cost and state the plan term next to every price, so you can see which figure needs a commitment.
Sources
- Eden, GLP-1 weight-loss pricing eden.health/glp-1/weight-loss (read 2026-10-15)
- NexLife semaglutide plans nexlife.us/pages/semaglutide-all-plans (read 2026-10-15)
- OrderlyMeds pricing orderlymeds.com/pricing/ (read 2026-10-15)
- Mochi Health per-dose pricing joinmochi.com/blog/per-dose-pricing-mochi-health (read 2026-10-15)
- Henry Meds GLP-1 weight management henrymeds.com/treatments/weight-management/glp-1-weight-management (read 2026-10-15)
- FDA, concerns with unapproved GLP-1 drugs fda.gov/drugs/postmarket-drug-safety-information-patients-and-provi (read 2026-10-15)